Google AI
NewsPronto

 

ACN Newswire

Read more press releases from ACN Newswire here

Singapore eDevelopment (SGX:40V) Subsidiary, Global BioLife, Proudly Announces Presentation of Parkinson's Research at Neuroscience 2018

  • Written by: ACN Newswire

image

SINGAPORE, Nov 7, 2018 - (ACN Newswire) - Singapore Exchange-listed Singapore eDevelopment Limited (Stock Code 40V) ("SeD"), through its subsidiary, Global BioLife Inc. ("Global BioLife") is pleased to announce that research of their promising drug platform, Linebacker, will be presented at Neuroscience 2018, the Annual Meeting for the...

Read more: Singapore eDevelopment (SGX:40V) Subsidiary, Global BioLife, Proudly Announces Presentation of...